Hodgkin's lymphoma is a type of cancer that affects the lymphatic system, a part of the body's immune system. It typically starts in lymph nodes and can spread to other parts of the body. While it can affect people of all ages, it is most common in young adults and older adults, and early detection and treatment are crucial for a good outcome.
Hodgkin's lymphoma (HL) is a lymphoid malignancy characterized by the presence of Reed-Sternberg cells within a reactive inflammatory infiltrate. It typically arises in lymph nodes and spreads in a predictable fashion to contiguous nodal groups. HL is generally considered one of the more curable forms of cancer.
| Condition | Distinguishing Feature |
|---|---|
| Non-Hodgkin Lymphoma (NHL) | NHL is more heterogeneous, often involves extranodal sites, and lacks Reed-Sternberg cells. |
| Tuberculosis | May present with lymphadenopathy and constitutional symptoms, but typically has a more insidious onset and may involve other organ systems. |
| Infectious Mononucleosis | Presents with lymphadenopathy, fever, and pharyngitis, but is usually self-limiting and associated with Epstein-Barr virus. |
| Sarcoidosis | Can cause mediastinal lymphadenopathy and constitutional symptoms, but typically involves other organs like the lungs and skin. |
| Metastatic Carcinoma | Can present with lymphadenopathy, but usually originates from a known primary tumor and may have a more rapid progression. |
| Reactive Lymphadenopathy | Often associated with infection or inflammation, typically resolves with treatment of the underlying cause and lacks Reed-Sternberg cells. |
Treatment for Hodgkin's lymphoma is highly effective and typically involves combination chemotherapy (e.g., ABVD regimen) and/or radiation therapy. The specific treatment plan depends on the stage of the disease, the presence of risk factors, and the patient's overall health. Autologous stem cell transplantation may be considered for relapsed or refractory disease.